Article Contents
EDITORIAL   Open Access     Cite

Beyond a positive label: Treatment-specific biomarkers for targeted cancer therapy

More Information
  • Corresponding author: hzeng15@fudan.edu.cn
  • 加载中
  • [1] U.S. Food and Drug Administration. (2026). FDA approves zanidatamab-hrii and tislelizumab-jsgr for HER2-positive gastric, gastroesophageal junction, or esophageal adenocarcinoma. August 25, 2026. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-zanidatamab-hrii-and-tislelizumab-jsgr-her2-positive-gastric-gastroesophageal-junction (Accessed October 3, 2026

    View in Article Google Scholar

    [2] Shitara K., Elimova E., Liu T., et al. (2026). Zanidatamab with and without Tislelizumab in HER2-positive gastroesophageal cancer. N. Engl. J. Med. 394:2002−2014. DOI:10.1056/NEJMoa2517729

    View in Article CrossRef Google Scholar

    [3] Li Z.-M., Zhou Z., He Z.-Y., et al. (2026). SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial. Cancer Cell 44:1832−1846.e2. DOI:10.1016/j.ccell.2026.07.012

    View in Article CrossRef Google Scholar

    [4] Chen W., Bai H., Huo Y., et al. (2025). Targeting IGF2BP2–CEMIP boosts antiangiogenic therapy in colorectal cancer in mice. Engineering 52:229−243. DOI:10.1016/j.eng.2025.06.035

    View in Article CrossRef Google Scholar

    [5] Simon R.M., Paik S. and Hayes D.F. (2009). Use of archived specimens in evaluation of prognostic and predictive biomarkers. J. Natl. Cancer Inst. 101:1446−1452. DOI:10.1093/jnci/djp335

    View in Article CrossRef Google Scholar

  • Cite this article:

    Zeng H. (2026). Beyond a positive label: Treatment-specific biomarkers for targeted cancer therapy. The Innovation Oncology 1:100031. https://doi.org/10.59717/j.xinn-oncol.2026.100031
    Zeng H. (2026). Beyond a positive label: Treatment-specific biomarkers for targeted cancer therapy. The Innovation Oncology 1:100031. https://doi.org/10.59717/j.xinn-oncol.2026.100031

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(171) PDF downloads(56)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint